CYCCP Archived Articles
Cyclacel Pharmaceuticals, Inc. (CYCC): A Resilient Biotech Navigating Challenges and Pursuing Promising Cancer Therapies
Published on March 11, 2025
Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC): A Precision Medicine Play Targeting Unmet Needs in Oncology
Published on November 28, 2024